Peregrine Capital Management LLC Purchases 6,661 Shares of Stevanato Group S.p.A. (NYSE:STVN)

Peregrine Capital Management LLC increased its holdings in shares of Stevanato Group S.p.A. (NYSE:STVN) by 1.9% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 366,078 shares of the company’s stock after purchasing an additional 6,661 shares during the period. Peregrine Capital Management LLC owned 0.12% of Stevanato Group worth $7,977,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of STVN. Wellington Management Group LLP increased its holdings in Stevanato Group by 4.5% in the 3rd quarter. Wellington Management Group LLP now owns 2,693,588 shares of the company’s stock worth $53,872,000 after buying an additional 115,050 shares during the period. Jennison Associates LLC purchased a new position in Stevanato Group during the fourth quarter valued at $20,239,000. Glenmede Trust Co. NA boosted its holdings in Stevanato Group by 12.7% in the 3rd quarter. Glenmede Trust Co. NA now owns 35,941 shares of the company’s stock worth $719,000 after buying an additional 4,050 shares during the last quarter. AMI Asset Management Corp purchased a new stake in shares of Stevanato Group during the fourth quarter worth approximately $1,089,000. Finally, Conestoga Capital Advisors LLC grew its holdings in shares of Stevanato Group by 5.3% during the fourth quarter. Conestoga Capital Advisors LLC now owns 8,082,996 shares of the company’s stock worth $176,128,000 after buying an additional 407,086 shares in the last quarter.

Analyst Ratings Changes

A number of brokerages recently commented on STVN. Bank of America lifted their price objective on Stevanato Group from $24.00 to $26.00 and gave the stock a “buy” rating in a research report on Friday, December 13th. Morgan Stanley reaffirmed an “equal weight” rating and issued a $23.00 target price (down previously from $24.00) on shares of Stevanato Group in a report on Tuesday, December 3rd. Finally, Wolfe Research started coverage on Stevanato Group in a report on Friday, December 13th. They issued an “outperform” rating and a $28.00 price target for the company. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Stevanato Group presently has an average rating of “Moderate Buy” and a consensus price target of €28.60 ($29.79).

Stevanato Group Stock Up 3.4 %

STVN opened at €20.20 ($21.04) on Wednesday. Stevanato Group S.p.A. has a 12 month low of €16.56 ($17.25) and a 12 month high of €34.00 ($35.42). The business has a 50-day moving average of €21.89 and a two-hundred day moving average of €20.53. The stock has a market capitalization of $6.12 billion, a price-to-earnings ratio of 42.98, a price-to-earnings-growth ratio of 6.86 and a beta of 0.56. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.81 and a quick ratio of 1.21.

Stevanato Group Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.